The Industrialist of the Skies – Scaling with "Automotive DNA
Archer Aviation bets that air taxis can move from flashy prototypes to real-world production, helped by Stellantis’ car-making know-how and a factory being built to churn out aircraft at scale. The big swing factor is getting regulators to approve its Midnight aircraft, which could turn today’s high-risk story into an actual commercial launch.Read more
5E Advanced Materials (FEAM): A Binary Critical Minerals Play with a $6.65 Fair Value Target
This company is trying to turn a research-stage boron project into a real producer, and the next round of government decisions could make or break that plan. The upside depends on landing major funding and signing firm customer deals, while delays could force more share sales and leave existing investors with much less.Read more
The "AI-Immunology" Asymmetric Opportunity – Validated by Merck (MSD)
Evaxion Biotech is a micro-cap TechBio company punching significantly above its weight class. While the market views it as a small preclinical player, its proprietary AI-Immunology™ platform has already secured a massive validation: a partnership with Merck (MSD).Read more
The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era
Voyager Technologies presents a unique arbitrage opportunity. The market is currently pricing it as a low-growth defense contractor (based on its Q3 revenue of ~$40M), completely ignoring the massive "hidden asset" on its balance sheet: Starlab.Read more
Moving from "Science Fiction" to "Science Fact" – A Bullish Valuation Case
Recursion Pharmaceuticals is currently at a critical inflection point. For years, the company was viewed as a "science project"—a high-tech platform promising to revolutionize drug discovery with AI.Read more
Efficiency is the New Growth: Dynatrace is the Ultimate "Consolidation" Play
The market currently prices Dynatrace as a "Steady Eddie" in the observability space, overshadowing the massive transformation occurring under the hood. While competitors chase "growth at all costs," Dynatrace has positioned itself as the "CFO’s Choice"—the only platform capable of delivering massive cost savings through tool consolidation while offering the most precise AI for the Global 1000.Read more
The "David vs. Goliath" AI Trade – Why Second Place is Worth Billions
AMD may not be the loudest name in AI chips, but big cloud companies want a real alternative to Nvidia and are backing AMD to avoid being stuck with one supplier. As AMD’s newest chips gain traction and its earlier Xilinx deal opens doors in “edge” AI, the business could look very different than the market expects.Read more
The "Physical AI" Monopoly – A New Industrial Revolution
Tesla ($TSLA) has officially exited the automotive peer group. By dismantling legacy Model S/X lines to build humanoid robots, the company has declared its transition from a car manufacturer to the world’s first "Physical AI" platform.Read more